Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil
Author Information
Author(s): Mannion Melissa, Cron Randy Q
Primary Institution: University of Alabama at Birmingham School of Medicine
Hypothesis
Can mycophenolate mofetil effectively treat pediatric autoimmune pancreatitis associated with elevated IgG4 levels?
Conclusion
The 13-year-old girl with IgG4 related systemic disease was successfully treated with mycophenolate mofetil, allowing for the discontinuation of corticosteroids.
Supporting Evidence
- The patient had elevated IgG4 levels and was diagnosed with autoimmune pancreatitis.
- Treatment with mycophenolate mofetil led to significant improvement in symptoms and laboratory findings.
- After one year of treatment, the patient was symptom-free and off all immunosuppressive therapy.
Takeaway
A girl with a rare type of pancreatitis got better after taking a special medicine instead of steroids, which helped her feel good without side effects.
Methodology
The case of a 13-year-old girl was presented, detailing her symptoms, diagnosis, treatment with mycophenolate mofetil, and follow-up results.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
13-year-old Caucasian female.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website